A year later, continuing to move at the speed of science, Pfizer delivered the first FDA-authorized oral antiviral treatment for COVID-19 by implementing the same sense of urgency and new ways of working that had made the vaccine program so successful. Refusing to accept public funding and instead investing more than $2 billion dollars at-risk, Albert inspired colleagues to deliver a safe and effective vaccine in just eight months – a process that typically take 8-10 years – without compromising quality or integrity. To create a culture in which the company’s people and science could thrive, Albert and his leadership team established Pfizer’s Purpose Blueprint, which included four core values: courage, excellence, equity and joy.Ī powerful example of Pfizer’s capabilities and culture was seen in the company’s response to the COVID-19 pandemic. When he took the reins as CEO in January 2019, Albert accelerated Pfizer’s transformation to become a more science-driven, innovative company – divesting its consumer and off-patent products businesses and dramatically increasing its R&D and digital innovation budgets. The global nature of his work – having lived and worked in eight different cities and led teams across five continents – has informed his understanding of the needs of patients and healthcare systems around the world and deepened his commitment to helping ensure equitable access to medicines and vaccines. As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose, Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.ĭuring his more than 25 years at Pfizer, Albert has built a diverse and successful career, holding several senior positions across a range of markets and disciplines.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |